A/S, a global healthcare giant specializing in diabetes care and obesity treatment, continues to dominate the GLP-1 drug market alongside competitor Eli Lilly (NYSE:LLY). With a market capitalization ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback